JP2009535330A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009535330A5 JP2009535330A5 JP2009507637A JP2009507637A JP2009535330A5 JP 2009535330 A5 JP2009535330 A5 JP 2009535330A5 JP 2009507637 A JP2009507637 A JP 2009507637A JP 2009507637 A JP2009507637 A JP 2009507637A JP 2009535330 A5 JP2009535330 A5 JP 2009535330A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- dysfunction
- antisecretory
- fragments
- pharmaceutically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0600933-6 | 2006-04-27 | ||
| SE0600933 | 2006-04-27 | ||
| US92082607P | 2007-03-30 | 2007-03-30 | |
| US60/920,826 | 2007-03-30 | ||
| PCT/SE2007/000415 WO2007126365A2 (en) | 2006-04-27 | 2007-04-27 | Further medical uses of antisecretory protein |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014013388A Division JP6063401B2 (ja) | 2006-04-27 | 2014-01-28 | 脂質ラフトの調節 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009535330A JP2009535330A (ja) | 2009-10-01 |
| JP2009535330A5 true JP2009535330A5 (enExample) | 2010-06-17 |
| JP5508846B2 JP5508846B2 (ja) | 2014-06-04 |
Family
ID=38655930
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009507637A Expired - Fee Related JP5508846B2 (ja) | 2006-04-27 | 2007-04-27 | 脂質ラフトの調節 |
| JP2014013388A Expired - Fee Related JP6063401B2 (ja) | 2006-04-27 | 2014-01-28 | 脂質ラフトの調節 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014013388A Expired - Fee Related JP6063401B2 (ja) | 2006-04-27 | 2014-01-28 | 脂質ラフトの調節 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8487074B2 (enExample) |
| EP (1) | EP2037950B1 (enExample) |
| JP (2) | JP5508846B2 (enExample) |
| KR (1) | KR20090037992A (enExample) |
| AU (1) | AU2007244005B2 (enExample) |
| CA (1) | CA2650132C (enExample) |
| IL (1) | IL194775A (enExample) |
| MX (1) | MX2008013777A (enExample) |
| PL (1) | PL2037950T3 (enExample) |
| WO (1) | WO2007126365A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG171602A1 (en) * | 2006-04-27 | 2011-06-29 | Lantmaennen As Faktor Ab | Use of antisecretory factors for treating intraocular hypertension |
| KR20090037992A (ko) | 2006-04-27 | 2009-04-17 | 란트만넨 아스-팍토르 아베 | 항분비 단백질의 추가적 의학 용도 |
| PL2040734T3 (pl) | 2006-04-27 | 2012-04-30 | Lantmaennen As Faktor Ab | Białko przeciwwydzielnicze do zastosowania w leczeniu zespołu przedziału |
| US9962424B2 (en) | 2007-04-27 | 2018-05-08 | Lantmännen As-Faktor Ab | Use of antisecretory factors (AF) for optimizing cellular uptake |
| US8901083B2 (en) | 2008-11-25 | 2014-12-02 | Temple University | Administration of angiocidin for the treatment of leukemia |
| JP5820277B2 (ja) | 2009-02-11 | 2015-11-24 | ラントメネン・アーエス−ファクトール・アーベー | 細胞取込を最適化するための抗分泌性因子（ａｆ）の使用 |
| WO2017009004A1 (en) | 2015-07-10 | 2017-01-19 | Lantmännen As-Faktor Ab | Process for producing egg yolk with high content of af-16 |
| US11407796B2 (en) | 2016-07-18 | 2022-08-09 | Lantmännen As-Faktor Ab | Antisecretory factor 17 |
| WO2020002464A1 (en) | 2018-06-28 | 2020-01-02 | Lantmännen Medical Ab | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure |
| WO2022159845A1 (en) * | 2021-01-22 | 2022-07-28 | University Of Virginia Patent Foudation | Altering protein function by pharmacological targeting of membrane domains |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585401A (en) | 1994-12-09 | 1996-12-17 | The Reents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
| SE508609C2 (sv) | 1995-08-24 | 1998-10-19 | Rural Patent Svenska Ab | Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning |
| WO1997027296A1 (en) * | 1996-01-26 | 1997-07-31 | Hsc Research And Development Limited Partnership | Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| SE9604251L (sv) | 1996-11-20 | 1997-12-22 | Svenska Lantmaennen Riksfoerbu | Födoämne som vid förtäring inducerar antisekretoriska proteiner |
| SE513496C2 (sv) | 1998-12-17 | 2000-09-18 | Rural Patent Svenska Ab | NASP-berikad äggula samt dess användning |
| GB0322645D0 (en) * | 2003-09-26 | 2003-10-29 | Melacure Therapeutics Ab | Use of antisecretory factor peptides |
| KR20090037992A (ko) | 2006-04-27 | 2009-04-17 | 란트만넨 아스-팍토르 아베 | 항분비 단백질의 추가적 의학 용도 |
| PL2040734T3 (pl) * | 2006-04-27 | 2012-04-30 | Lantmaennen As Faktor Ab | Białko przeciwwydzielnicze do zastosowania w leczeniu zespołu przedziału |
| EP2682819A2 (en) * | 2012-07-04 | 2014-01-08 | Xeikon IP B.V. | A method for forming a multi-colour image |
-
2007
- 2007-04-27 KR KR1020087029121A patent/KR20090037992A/ko not_active Ceased
- 2007-04-27 WO PCT/SE2007/000415 patent/WO2007126365A2/en not_active Ceased
- 2007-04-27 MX MX2008013777A patent/MX2008013777A/es active IP Right Grant
- 2007-04-27 JP JP2009507637A patent/JP5508846B2/ja not_active Expired - Fee Related
- 2007-04-27 CA CA2650132A patent/CA2650132C/en not_active Expired - Fee Related
- 2007-04-27 EP EP07748080.4A patent/EP2037950B1/en not_active Not-in-force
- 2007-04-27 PL PL07748080T patent/PL2037950T3/pl unknown
- 2007-04-27 AU AU2007244005A patent/AU2007244005B2/en not_active Ceased
-
2008
- 2008-10-22 IL IL194775A patent/IL194775A/en active IP Right Grant
- 2008-10-27 US US12/289,390 patent/US8487074B2/en not_active Expired - Fee Related
-
2014
- 2014-01-28 JP JP2014013388A patent/JP6063401B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102946621B1 (ko) | 몬테루카스트와 펩티드의 새로운 접합체 | |
| KR102004668B1 (ko) | 아드레노메둘린의 폴리에틸렌 글리콜 기반 전구약물 및 그의 용도 | |
| JP7571035B2 (ja) | Ｃｎｐコンジュゲートの乾燥医薬製剤 | |
| JP6557684B2 (ja) | 線維性疾患の治療に用いられるｐｐａｒ化合物 | |
| CN105143170A (zh) | 用于治疗肺纤维化、肝纤维化、皮肤纤维化和心脏纤维化的经取代的芳族化合物 | |
| US10016397B2 (en) | Selective AT2 receptor agonists for use in treatment of cachexia | |
| TW200827370A (en) | Novel compounds and their effects on feeding behaviour | |
| JP2014074048A (ja) | 急性肺損傷におけるａｎｇ−（１−７）レセプターアゴニストの使用 | |
| KR20030038547A (ko) | 울혈심부전을 치료하기 위한 프로스타글란딘 화합물 | |
| CN101433717A (zh) | 含有食糜酶抑制剂和ace抑制剂作为有效成分的药物 | |
| US10716825B2 (en) | Method of treating a liver disease comprising administering ostreolysin orfunctionally related variant thereof | |
| JP2017519799A (ja) | 低血圧の治療方法 | |
| CA2997131A1 (en) | Long-acting adrenomedullin derivative | |
| CN110437311A (zh) | 一种多肽及其应用 | |
| EA201101211A1 (ru) | 5-(2-{[6-(2,2-дифтор-2-фенилэтокси)гексил]амино}-l-гидроксиэтил)-8-гидроксихинолин-2(1h)-oh и его применение для лечения легочных заболеваний | |
| ES2311973T3 (es) | Ctgf como objetivo para la terapia de microalbuminuria en pacientes con nefropatia diabetica. | |
| SI24318A (sl) | Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji | |
| CN101578107A (zh) | 新颖化合物及其对进食行为的影响 | |
| KR20090083891A (ko) | Ｓ-니트로소티올 화합물 및 관련 유도체 | |
| CN110511285B (zh) | 一种重组融合多肽及其应用 | |
| US12398196B2 (en) | Fused polypeptide with multifunctional activities and use thereof | |
| JP2001518062A (ja) | 肺繊維症の治療 | |
| US20070117861A1 (en) | Treatment or prevention of cardiovascular and respiratory disorders with novel substituted cyclic-amp specific phosphodiesterase inhibitors | |
| US8476221B2 (en) | Methods and compositions for the treatment of metabolic disorders | |
| KR102967810B1 (ko) | 사이클로-히스프로 유도체 및 이를 포함하는 섬유증의 예방, 개선 또는 치료용 조성물 |